Biotronik

Delivering 42 Joules on first shock addresses patients with high defibrillation thresholds

Company says its new balloon is designed to enhance access to difficult lesions and challenging patient anatomies

Biotronik, is launching ProMRI® SystemCheck, a new online tool for tracking the ProMRI status of implantable devices.

It might seem obvious that the heightened level of care provided by remote monitoring of cardiovascular conditions would result in only good things for patients. A new study, published in The Lancet, confirms it.

Biotronik says the U.S. FDA has approved its Entovis pacemaker system with ProMRI® technology. The Entovis system allows patients to undergo MRI scans with a limited exclusion zone. FDA approval covers both single chamber (SR-T) and dual chamber (DR-T) Entovis pacemakers when implanted with Setrox pacing leads.

Cardiovascular device company Biotronik has announced that the first patients across the United States have received implants of the new Iforia implantable cardioverter-defibrillators (ICDs)

Remote monitoring of ICDs has been shown to improve patient adherence to follow-up regimes when compared with traditional repeat check-up appointments. It’s surely the biggest “no-brainer” the specialty has seen for years.

The U.S. FDA has said Biotronik can move onto phase C of its ProMRI study which will investigate the company’s MRI-compatible technology in its implantable cardioverter-defibrillator (ICD) devices.

Frequent visitor to our pages, cardiovascular device company Biotronik has announced the first implantations of the Sentus ProMRI® lead.

Cardiovascular device company Biotronik is in the news again with the announcement of its release of the Passeo-18 Lux Drug Releasing Balloon (DRB) in all countries accepting CE mark, following recent CE approval.

Biotronik is pointing to new study data showing that use of its Biotronik Home Monitoring® system has saved the French National Health Insurance system costs, in addition to being safe and efficient.

According to a well-known Berlin cardiologist, monitoring devices enable physicians to treat patients more effectively. The BioMonitor from BIOTRONIK is now approved for full-body MR scans.

Biotronik, a pioneer in MRI compatible Cardiovascular implants devices, tells us that the US FDA has approved an expansion of its ongoing ProMRI® trial. This will allow inclusion of additional patient cohorts into the study, providing further support for the company’s proposed claims.

Biotronik has seen its clever, electrospun coated stent gain CE mark approval for use in cases of acute coronary vessel perforation. The clever part lies in the electrospinning, which creates a single, integrated coating without the need to sandwich the stent.

Heart rhythm and home monitoring specialist Biotronik, has gained FDA approval for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D) devices.

Biotronik now boasts one of the longest drug-eluting stents on the market across all diameters with the market release of new 35 and 40 mm versions of Orsiro, the industry’s first hybrid Drug Eluting Stent (DES) featuring a bioabsorbable polymer.